Clinical Trial - Safety and Pharmacokinetic Study of Intravenous Ibuprofen - Fever

  • 1

1 Answer

These messages are for mutual support and information sharing only. Always consult your doctor before trying anything you read here.
The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of intravenous ibuprofen administered over approximately ten (10) minutes.  
Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 24 participants
Allocation: Single Group Assignment
Intervention Model: Multi-center, Open-label
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months
Actual Study Start Date: July 17, 2017
Estimated Primary Completion Date: December 2018
Estimated Study Completion Date: December 2018
Contact: Byron Kaelin 615-255-0068 ext 250
Contact: Jerry Fox 615-255-0068 ext 226 Identifier: NCT02583399
  For enrollment please visit